Iodixanol 320

DRUG3 trials

Sponsors

Deutsches Herzzentrum Muenchen, Bracco Diagnostics, Inc, Azienda Sanitaria Locale 9, Grosseto

Conditions

Angioplasty, Transluminal, Percutaneous CoronaryContrast Induced Acute Kidney InjuryCoronary ArteriosclerosisCoronary Artery StenosisRenal Insufficiency, Chronic

Early Phase 1

Contrast-inDuced nephRotoxicity as Assessed by the KIdney Load-to-DAmage RElationship

CompletedNCT01908309

Azienda Sanitaria Locale 9, GrossetoContrast Induced Acute Kidney Injury

Start: 2013-04-30End: 2014-10-31Updated: 2015-06-23

Phase 4

Iodixanol vs. Iomeprol to Prevent Contrast-Induced Nephropathy After Coronary Intervention (CONTRAST)

CompletedNCT00390585

Deutsches Herzzentrum MuenchenAngioplasty, Transluminal, Percutaneous Coronary, Coronary Arteriosclerosis, Renal Insufficiency, Chronic

Start: 2006-07-31End: 2008-12-31Updated: 2010-03-15

Kidney Damage In Patients With Severe Fall In eGFR

TerminatedNCT01136915

Bracco Diagnostics, IncCoronary Artery Stenosis

Start: 2010-11-30End: 2012-11-30Updated: 2014-03-17

Related Papers

Choice of contrast medium in patients with impaired renal function undergoing percutaneous coronary intervention.

2009-09-2231 citations